Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...

We tested powders from Clean Simple Eats, Equate, Premier Protein, Ritual, and Truvani. Our results show it’s possible to ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive prelimi ...

ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, ...

Assertio Holdings, Inc. ("Assertio" or the "Company") today announced that results of a clinical trial investigating a novel ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world applications in medicine and agriculture.

The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including ...

On December 18, 2025, the Food and Drug Administration (FDA) released a final guidance entitled “Processes and Practices Applicable to Bioresearch Monitoring Inspections.” The guidance was issued to ...

The FDA has updated guidance outlining how it applies regulatory flexibility to chemistry, manufacturing and control requirements for cell and gene therapies. The agency said the approach is meant to ...

FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

Following the announcement from the Department of Health and Human Services (HHS) of new rules that would end gender-affirming care for minors, the Food and Drug Administration (FDA) threatened ...